Skip to content

Effect of aerobic and resistance exercise training on the inflammatory markers in patients with breast cancer undergoing chemotherapy

Effect of exercise training on the inflammatory profile in patients with breast cancer undergoing chemotherapy: an open label randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098731
Enrollment
60
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Exercise: Aerobic exercise - home based walking exercise for 3 days per week Resistance training exercise - 2 days per week Stretching and breathing exercise for the rest of the days

Sponsors

Dr Rose Babu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients who are diagnosed with breast cancer (Stage 1 to stage 3) and about to undergo neoadjuvant or adjuvant chemotherapy (cyclophosphamide-anthracycline regimen). Normal cardiovascular, hepatic and renal function. Patients who are willing to participate.

Exclusion criteria

Exclusion criteria: Patients with Eastern Cooperative Oncology Group (ECOG) performance status more than 1. Currently with any musculoskeletal disturbances, severe respiratory illness, autoimmune diseases. Patients who are pregnant. Who had undergone major surgeries within past 3 months Known case of any psychiatric disorders, intellectual disabilities. Under regular moderate to high intensity exercise (after calculation of physical activity level (PAL). Receiving chronic anti-inflammatory medications for other diseases.

Design outcomes

Primary

MeasureTime frame
Inflammatory markerTimepoint: 3 time points. Baseline - before chemotherapy, 6 weeks- after mid and 12 weeks - at the end of chemotherapy cycles

Secondary

MeasureTime frame
Body composition, Muscle strength, Quality of lifeTimepoint: Baseline, 6 weeks after mid & 12 weeks at the end of chemotherapy cycles;Chemotherapy toxicity, Relative dose intensityTimepoint: 3 weeks, 6 weeks, 9 weeks & 12 weeks after every cycle of chemotherapy

Countries

India

Contacts

Public ContactDr Biju Bahuleyan

Jubilee Mission Medical College and Research Institute

drbijubahuleyan@gmail.com9846915151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026